An increasing number of recent studies have highlighted the importance of PD-1/PD-L pathway in immune regulation in CNS disorders such as ischemic stroke, multiple sclerosis, and Alzheimer’s disease. This evidence concerns the gene PDCD1 and early-onset autosomal dominant Alzheimer disease.